Brief: Boundless Bio Reports Fourth Quarter And Full Year 2024 Financial Results And Business Highlights
27/03/2025 11:41
March 27 (Reuters) - Boundless Bio Inc BOLD.O: BOUNDLESS BIO REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS BOUNDLESS BIO INC: QTRLY LOSS PER SHARE $0.74 Source text: ID:nGNX31kbGq Further company coverage: BOLD.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Boundless Bio
See all newsBoundless Bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Boundless Bio Inc expected to post a loss of 58 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Bath & Body Works, Avis Budget, Cerebras
U.S. STOCKS ON THE MOVE-Boundless Bio, Galectin, UniQure
Boundless Bio soars on merger with Serapha